An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.
Investigational Treatment Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the substance there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Concerns
However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Several professionals said the demand for retatrutide could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Implementation
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Research also discovered groups with up to 9,000 participants marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.
Product Information and Pricing
Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Safety Measures
A spokesperson for the messaging service stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Even if the science behind this drug is sound, these online versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her team has previously seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly serious health risks”.
